English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51343818    ???header.onlineuser??? :  581
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"wu s g"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 224  (23 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-08-10T02:37:41Z Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; Yu C.-J.; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2022-06-27T07:07:54Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:54Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S.-G.; Gow C.-H.; CHONG-JEN YU; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:53Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; CHONG-JEN YU; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:35Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:32Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏 2022-06-27T07:07:28Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:27Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:06:27Z Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation Wu S.-G.; Shih J.-Y.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:21Z Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C.

Showing items 1-10 of 224  (23 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page